{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:38:27Z","timestamp":1788212307959,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A2C1011351"],"award-info":[{"award-number":["NRF-2021R1A2C1011351"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To analyse the incidence of complications following radiotherapy (RT) in patients with Graves\u2019 orbitopathy (GO), particularly focusing on the incidence of radiation retinopathy and associated risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data on diagnosed GO patients who received RT between 2008 and 2018 were obtained from the National Health Insurance Service database. The diagnosis of GO and the administration of RT were assessed utilising the International Classification of Diseases codes. The incidence of RT-related complications was analysed. Logistic regression was used to identify risk factors for radiation retinopathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 1108 patients who received RT for GO between 2008 and 2018, 67 patients (6.0%) were newly diagnosed with cataracts, and 42 patients (3.8%) underwent surgery. Ocular surface disease, dry eye syndrome, eyelid inflammation, and head and neck cancer occurred in 14 patients (1.3%), 37 patients (3.3%), 8 patients (0.7%), and 2 patients (0.2%), respectively, and no cases of leukaemia or lymphoma were observed. Radiation retinopathy developed in 63 patients (5.7%). In comparison to those without radiation retinopathy, patients with radiation retinopathy had a short interval from GO diagnosis to RT (odds ratio (OR)\u2009=\u20090.95, 95% CI\u2009=\u20090.92\u20130.98,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003) and high fasting blood sugar levels (OR\u2009=\u20091.01, 95% CI\u2009=\u20091.00\u20131.03,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.014).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with GO, cataract, radiation retinopathy, dry eye syndrome, ocular surface disease, and head and neck cancers are potential complications of orbital RT. Risk factor identification and long-term monitoring are crucial for minimising treatment-related complications and improving patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-026-04284-9","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:38:48Z","timestamp":1771670328000},"page":"1067-1073","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Complications after radiotherapy in patients with Graves\u2019 orbitopathy: A nationwide cohort study"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3246-5246","authenticated-orcid":false,"given":"Jooyoung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa Young","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Sun","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9797-9945","authenticated-orcid":false,"given":"Jeong Kyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"key":"4284_CR1","first-page":"444","volume":"36","author":"E Piantanida","year":"2013","unstructured":"Piantanida E, Tanda ML, Lai A, Sassi L, Bartalena L. Prevalence and natural history of Graves\u2019 orbitopathy in the XXI century. J Endocrinol Invest. 2013;36:444\u20139.","journal-title":"J Endocrinol Invest"},{"key":"4284_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/thy.1999.9.305","volume":"9","author":"D Yang","year":"1999","unstructured":"Yang D, Hiromatsu Y, Hoshino T, Inoue Y, Itoh K, Nonaka K. Dominant infiltration of T(H)1-type CD4+ T cells at the retrobulbar space of patients with thyroid-associated ophthalmopathy. Thyroid. 1999;9:305\u201310.","journal-title":"Thyroid"},{"key":"4284_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40265-018-1045-9","volume":"79","author":"N Genere","year":"2019","unstructured":"Genere N, Stan MN. Current and Emerging Treatment Strategies for Graves\u2019 Orbitopathy. Drugs. 2019;79:109\u201324.","journal-title":"Drugs"},{"key":"4284_CR4","first-page":"99","volume":"59","author":"H Thomas","year":"1936","unstructured":"Thomas H, Woods A. Progressive exophthalmos following thyroidectomy. Bull Johns Hopkins Hosp. 1936;59:99\u2013113.","journal-title":"Bull Johns Hopkins Hosp"},{"key":"4284_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1910434","volume":"382","author":"RS Douglas","year":"2020","unstructured":"Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, et al. Teprotumumab for the Treatment of Active Thyroid Eye Disease. N Engl J Med. 2020;382:341\u201352.","journal-title":"N Engl J Med"},{"key":"4284_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijrobp.2010.08.053","volume":"82","author":"C Matthiesen","year":"2012","unstructured":"Matthiesen C, Thompson JS, Thompson D, Farris B, Wilkes B, Ahmad S, et al. The efficacy of radiation therapy in the treatment of Graves\u2019 orbitopathy. Int J Radiat Oncol Biol Phys. 2012;82:117\u201323.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4284_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1089\/105072502753600223","volume":"12","author":"L Bartalena","year":"2002","unstructured":"Bartalena L, Marcocci C, Tanda ML, Rocchi R, Mazzi B, Barbesino G, et al. Orbital radiotherapy for Graves\u2019 ophthalmopathy. Thyroid. 2002;12:245\u201350.","journal-title":"Thyroid"},{"key":"4284_CR8","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ijrobp.2010.09.056","volume":"79","author":"VS Jeganathan","year":"2011","unstructured":"Jeganathan VS, Wirth A, MacManus MP. Ocular risks from orbital and periorbital radiation therapy: a critical review. Int J Radiat Oncol Biol Phys. 2011;79:650\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4284_CR9","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1001\/archopht.1984.01040031193016","volume":"102","author":"JL Kinyoun","year":"1984","unstructured":"Kinyoun JL, Kalina RE, Brower SA, Mills RP, Johnson RH. Radiation retinopathy after orbital irradiation for Graves\u2019 ophthalmopathy. Arch Ophthalmol. 1984;102:1473\u20136.","journal-title":"Arch Ophthalmol"},{"key":"4284_CR10","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2003-030260","volume":"88","author":"C Marcocci","year":"2003","unstructured":"Marcocci C, Bartalena L, Rocchi R, Marin\u00f2 M, Menconi F, Morabito E, et al. Long-term safety of orbital radiotherapy for Graves\u2019 ophthalmopathy. J Clin Endocrinol Metab. 2003;88:3561\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"4284_CR11","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1055\/s-0043-116945","volume":"49","author":"M Oeverhaus","year":"2017","unstructured":"Oeverhaus M, Witteler T, Lax H, Esser J, F\u00fchrer D, Eckstein A. Combination Therapy of Intravenous Steroids and Orbital Irradiation is More Effective Than Intravenous Steroids Alone in Patients with Graves\u2019 Orbitopathy. Horm Metab Res. 2017;49:739\u201347.","journal-title":"Horm Metab Res"},{"key":"4284_CR12","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.ijrobp.2010.09.015","volume":"82","author":"CC Cardoso","year":"2012","unstructured":"Cardoso CC, Giordani AJ, Wolosker AM, Souhami L, Manso PG, Dias RS, et al. Protracted hypofractionated radiotherapy for Graves\u2019 ophthalmopathy: a pilot study of clinical and radiologic response. Int J Radiat Oncol Biol Phys. 2012;82:1285\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4284_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/IOP.0000000000001003","volume":"34","author":"KG Gold","year":"2018","unstructured":"Gold KG, Scofield S, Isaacson SR, Stewart MW, Kazim M. Orbital Radiotherapy Combined With Corticosteroid Treatment for Thyroid Eye Disease-Compressive Optic Neuropathy. Ophthalmic Plast Reconstr Surg. 2018;34:172\u20137.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"4284_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.prro.2014.02.008","volume":"4","author":"E Hahn","year":"2014","unstructured":"Hahn E, Laperriere N, Millar BA, Oestreicher J, McGowan H, Krema H, et al. Orbital radiation therapy for Graves\u2019 ophthalmopathy: measuring clinical efficacy and impact. Pract Radiat Oncol. 2014;4:233\u20139.","journal-title":"Pract Radiat Oncol"},{"key":"4284_CR15","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/archopht.121.5.652","volume":"121","author":"DM Robertson","year":"2003","unstructured":"Robertson DM, Buettner H, Gorman CA, Garrity JA, Fatourechi V, Bahn RS, et al. Retinal microvascular abnormalities in patients treated with external radiation for graves ophthalmopathy. Arch Ophthalmol. 2003;121:652\u20137.","journal-title":"Arch Ophthalmol"},{"key":"4284_CR16","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.ophtha.2003.12.054","volume":"111","author":"IM Wakelkamp","year":"2004","unstructured":"Wakelkamp IM, Tan H, Saeed P, Schlingemann RO, Verbraak FD, Blank LE, et al. Orbital irradiation for Graves\u2019 ophthalmopathy: Is it safe? A long-term follow-up study. Ophthalmology. 2004;111:1557\u201362.","journal-title":"Ophthalmology"},{"key":"4284_CR17","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00417-016-3280-7","volume":"254","author":"JW Kim","year":"2016","unstructured":"Kim JW, Han SH, Son BJ, Rim TH, Keum KC, Yoon JS. Efficacy of combined orbital radiation and systemic steroids in the management of Graves\u2019 orbitopathy. Graefes Arch Clin Exp Ophthalmol. 2016;254:991\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4284_CR18","first-page":"e84427","volume":"17","author":"L Nicosia","year":"2019","unstructured":"Nicosia L, Reverberi C, Agolli L, Marinelli L, De Sanctis V, Minniti G, et al. Orbital Radiotherapy Plus Concomitant Steroids in Moderate-to-Severe Graves\u2019 Ophthalmopathy: Good Results After Long-Term Follow-Up. Int J Endocrinol Metab. 2019;17:e84427.","journal-title":"Int J Endocrinol Metab"},{"key":"4284_CR19","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0161-6420(02)01293-9","volume":"109","author":"CA Gorman","year":"2002","unstructured":"Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, et al. The aftermath of orbital radiotherapy for Graves\u2019 ophthalmopathy. Ophthalmology. 2002;109:2100\u20137.","journal-title":"Ophthalmology"},{"key":"4284_CR20","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C, et al. The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur J Endocrinol. 2021;185:G43\u2013g67.","journal-title":"Eur J Endocrinol"},{"key":"4284_CR21","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1055\/s-0042-114043","volume":"233","author":"K Hurtikova","year":"2016","unstructured":"Hurtikova K, von Arx G, Fichter N, Gerding H. Radiation Retinopathy 15 Years after Orbital Irradiation for Thyroid Orbitopathy. Klin Monbl Augenheilkd. 2016;233:e2.","journal-title":"Klin Monbl Augenheilkd"},{"key":"4284_CR22","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0360-3016(01)01699-6","volume":"51","author":"SD Marquez","year":"2001","unstructured":"Marquez SD, Lum BL, McDougall IR, Katkuri S, Levin PS, MacManus M, et al. Long-term results of irradiation for patients with progressive Graves\u2019 ophthalmopathy. Int J Radiat Oncol Biol Phys. 2001;51:766\u201374.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4284_CR23","doi-asserted-by":"crossref","unstructured":"Takahashi Y, Vaidya A, Kakizaki H. Changes in dry eye status after steroid pulse and orbital radiation therapies in active thyroid eye disease. J Clin Med. 2022;11:3604.","DOI":"10.3390\/jcm11133604"},{"key":"4284_CR24","doi-asserted-by":"publisher","first-page":"1428185","DOI":"10.3389\/fendo.2024.1428185","volume":"15","author":"MN Maglionico","year":"2024","unstructured":"Maglionico MN, Lanzolla G, Figus M, Cosentino G, Comi S, Marin\u00f2 M, et al. Ocular surface disease index in Graves\u2019 orbitopathy: a cross-sectional study. Front Endocrinol. 2024;15:1428185.","journal-title":"Front Endocrinol"},{"key":"4284_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0360-3016(01)01754-0","volume":"52","author":"U Schaefer","year":"2002","unstructured":"Schaefer U, Hesselmann S, Micke O, Schueller P, Bruns F, Palma C, et al. A long-term follow-up study after retro-orbital irradiation for Graves\u2019 ophthalmopathy. Int J Radiat Oncol Biol Phys. 2002;52:192\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4284_CR26","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0161-6420(02)01848-1","volume":"110","author":"L Bartalena","year":"2003","unstructured":"Bartalena L. Orbital radiation therapy for Graves\u2019 ophthalmopathy. Ophthalmology. 2003;110:452\u20133.","journal-title":"Ophthalmology"},{"key":"4284_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000422432","volume":"25","author":"C Marcocci","year":"1993","unstructured":"Marcocci C, Bartalena L, Bruno-Bossio G, Vanni G, Cartei F, Bogazzi F, et al. Orbital radiotherapy in the treatment of endocrine ophthalmopathy: when and why?. Dev Ophthalmol. 1993;25:131\u201341.","journal-title":"Dev Ophthalmol"},{"key":"4284_CR28","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S0140-6736(05)78494-4","volume":"351","author":"B Nygaard","year":"1998","unstructured":"Nygaard B, Specht L. Transitory blindness after retrobulbar irradiation of Graves\u2019 ophthalmopathy. Lancet. 1998;351:725\u20136.","journal-title":"Lancet"},{"key":"4284_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, et al. The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy Guidelines for the Management of Graves\u2019 Orbitopathy. Eur Thyroid J. 2016;5:9\u201326.","journal-title":"Eur Thyroid J"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04284-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04284-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04284-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:29:34Z","timestamp":1778488174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04284-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4284"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04284-9","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"14 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF-2021R1A2C1011351). The funding organisation had no role in the design or conduct of this research. The authors have no other conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}